| 标题 |
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Roy S. Herbst; Paul Baas; Dong‐Wan Kim; Enriqueta Felip; José Luis Perez‐Gracia; et al 出版日期:2015-12-19 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)